Propiedad y actividad de insiders de Nanobiotix S.A. (NBTX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $34.40 |
| Capitalización | $1.7B |
| Bolsa | NASDAQ |
| País | FR |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $21.1M | $47.2M | $36.2M | $35.1M | $119.2M | $83.9M | $41.4M | $75.3M | $49.7M | $52.8M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $5207 | $844000 | $997000 | $1.3M | $3.9M | $3.9M | $2.8M | $3.0M | $8.5M | $7.7M |
| Inventario | -$5.0M | -$4.9M | $1.1M | $2.7M | 0 | 0 | $3.0M | $200000 | 0 | 0 |
| Activos Corrientes | $26.9M | $53.1M | $42.7M | $46.1M | $125.2M | $93.1M | $52.4M | $87.3M | $61.5M | $62.8M |
| Inmovilizado Material | $2.4M | $3.0M | $2.9M | $9.4M | $8.3M | $8.2M | $7.1M | $6.1M | $5.5M | $4.6M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $4453 | $135968 | $102000 | $163000 | $21000 | $4000 | $1000 | $8000 | $7000 | $10000 |
| Activos Totales | $30.4M | $57.5M | $46.2M | $56.2M | $134.0M | $101.8M | $59.8M | $93.9M | $67.4M | $67.8M |
| Cuentas por Pagar | $4.4M | $5.1M | $4.5M | $6.2M | $5.6M | $5.0M | $4.0M | $6.7M | $4.5M | $6.6M |
| Deuda a Corto | $1.1M | $770000 | $500000 | $500000 | $3.7M | $7.1M | $3.6M | $3.8M | $3.7M | $3.1M |
| Pasivos Corrientes | $8.2M | $9.4M | $11.6M | $14.3M | $19.0M | $36.8M | $37.9M | $49.9M | $58.9M | $57.5M |
| Deuda a Largo | $4.6M | $3.7M | $20.0M | $37.6M | $39.1M | $32.4M | $44.0M | $41.7M | $43.0M | $89.1M |
| Pasivos Totales | $13.0M | $13.5M | $32.0M | $58.1M | $63.6M | $75.0M | $86.8M | $95.7M | $133.1M | $152.2M |
| Reservas | -$21.9M | -$26.1M | -$30.3M | -$50.9M | -$33.6M | -$47.0M | -$57.0M | -$39.7M | -$68.1M | -$24.0M |
| Patrimonio Neto | $17.4M | $43.9M | $14.2M | -$1.9M | $70.5M | $26.8M | -$27.0M | -$1.8M | -$65.7M | -$84.5M |
| Deuda Total | $5.7M | $4.7M | $20.5M | $44.5M | $49.0M | $46.0M | $53.2M | $50.6M | $50.9M | $95.3M |
| Deuda Neta | -$15.4M | -$42.5M | -$15.7M | $9.4M | -$70.2M | -$38.1M | $11.8M | -$24.7M | $1.2M | $42.6M |
| Capital Circulante | $18.6M | $43.8M | $31.1M | $31.8M | $106.2M | $56.2M | $14.4M | $37.5M | $2.5M | $5.2M |
Salud financiera
| Deuda / Patrimonio | -1.13 |
| Ratio corriente | 1.09 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 3.22 |
Rentabilidad
| Rentabilidad sobre capital | 31.23% |
| Rentabilidad sobre capital invertido | -74.29% |
| Rentabilidad sobre activos | -35.36% |
| Margen bruto | 100.00% |
| Margen operativo | -36.49% |
| Margen neto | -80.83% |
Empresas relacionadas: ABUS · EYPT · GHRS · KURA · LENZ · PROK · RZLT
Explorar sector: Healthcare · Biotechnology
Más secciones de NBTX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones